Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Incyte Corp (NASDAQ:INCY)

81.27
Delayed Data
As of May 24
 +0.59 / +0.73%
Today’s Change
55.00
Today|||52-Week Range
133.62
-25.06%
Year-to-Date

Today’s Trading

Previous close80.68
Today’s open81.10
Day’s range80.32 - 81.77
Volume1,099,283
Average volume (3 months)2,024,013
Market cap$15.2B
Dividend yield--
Data as of 05/24/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+173.33%
Earnings growth (next 5 years)+56.00%
Revenue growth (last year)+47.36%
P/E ratio319.6
Price/Sales26.95
Price/Book88.63

Competitors

 Today’s
change
Today’s
% change
BMRNBiomarin Pharmaceuti...+2.44+2.85%
PRGOPerrigo Company PLC+2.76+2.95%
MDVNMedivation Inc+1.16+1.91%
JAZZJazz Pharmaceuticals...+3.44+2.32%
Data as of 05/24/2016

Financials

Next reporting dateJuly 28, 2016
EPS forecast (this quarter)-$0.02
Annual revenue (last year)$753.8M
Annual profit (last year)$6.5M
Net profit margin0.87%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Hervé Hoppenot
Chief Financial Officer &
Executive Vice President
David W. Gryska
Corporate headquarters
Wilmington, Delaware

Forecasts

Partner Offers

Search for Jobs